Events | 2016.01.07
Veritas Genetics Advances Access to Cancer Prevention with New Test for High-Risk Breast and Ovarian Cancer Patients
Veritas Genetics continues to advance hereditary breast and ovarian cancer (HBOC) prevention with the introduction of myBRCA HiRisk. As a new 26-gene screening panel, myBRCA HiRisk is a comprehensive HBOC screening test specifically designed for high-risk populations.
(PRWeb January 06, 2016)
Read the full story at http://www.prweb.com/releases/2016/01/prweb13151942.htm
For more information, please visit
http://www.prweb.com/releases/2016/01/prweb13151942.htm
